Publicacions - IR Sant Pau

Cercar

10/10/2025 Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk

León-Mengíbar, J, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Caixàs, A, Bueno, M, Ciudin, A, Hernández, M, Simó, R, Hernández, C, Lecube, A. Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1689960. PMID:41141356. IF:4.600(Q1/3D).

01/10/2025 The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024)

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).

01/10/2025 Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans

Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).

01/10/2025 Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study

Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).

01/10/2025 Executive summary of the document 'Diabetes Day Hospital. Value proposition'

Martin, FJES, Lesmes, IB, Peralta, FG, Torres, JFM, Gómez, FP, Ballesteros, AC, González-Clemente, JM, de Villar, NGP, Portillo, CM, Corrales, PJP, Engel, WR, de Inestrosa, MTBP, Fernández-Santos, CM, Arranz, E, Vinagre, GF, Perán, JF, Sedisa, Brocca, MAM. Executive summary of the document 'Diabetes Day Hospital. Value proposition'. Endocrinologia Diabetes y Nutricion. 2025; 72(8)DOI:10.1016/j.endien.2025.501601. PMID:40946027. IF:1.800(Q3/8D).

19/09/2025 Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study

Puig, R, Rojo-López, MI, Julve, J, Castelblanco, E, Ponomarenko, J, Amezqueta, S, Vendrell, J, Franch-Nadal, J, Torres, JL, Mauricio, D, Ramos-Romero, S. Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 2025; 17(18)DOI:10.3390/nu17183003. PMID:41010528. IF:5.000(Q1/2D).

18/09/2025 Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes

Milad, C, Viñals, C, Perea, V, Seres-Noriega, T, Blanco-Carrasco, A, Vinagre, I, Claro, M, Solà, C, Mesa, A, Ayala, D, Conget, I, Gimenez, M, Amor, AJ. Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70088. PMID:40965235. IF:6.000(Q1/2D).

03/09/2025 Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change

Páez-Espinosa, EV, Sosa-Guzmán, DM, Buitrón-Andrade, LR, Dávila-Jumbo, N, Cáceres-Ruiz, MI, Robalino-Flores, VF, Mato-Matute, E. Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change. Tropical Medicine and Infectious Disease. 2025; 10(9)DOI:10.3390/tropicalmed10090254. PMID:41003564. IF:2.600(Q1/1D).

01/09/2025 A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries

Voss, EA, Yuan, Z, Ali, SR, Bosan, R, Eworuke, E, Brewster, J, Vlacho, B, Fernández-Camins, B, Fernández-Bertolín, S, Fonseca, S, Jeffcoat, C, Wang, L. A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries. DIABETES OBESITY & METABOLISM. 2025; 27(9)DOI:10.1111/dom.16574. PMID:40605139. IF:5.700(Q1/2D).

01/09/2025 Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline

Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(9)DOI:10.1210/clinem/dgaf288. PMID:40652453. IF:5.100(Q1/2D).

25/08/2025 Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes

Viñals, C, Conget, I, Granados, M, Solà, C, Ayala, D, Mesa, A, Seres-Noriega, T, Domenech, M, Perea, V, Blanco, J, Vinagre, I, Gimenez, M, Amor, AJ. Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes. Journal of Clinical Medicine. 2025; 14(17)DOI:10.3390/jcm14176004. PMID:40943764. IF:2.900(Q1/2D).

01/08/2025 Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes

Claro, M, Viñals, C, Giménez, M, Perea, V, Granados, M, Serés-Noriega, T, Blanco, J, Vinagre, I, Mesa, A, Milad, C, Ayala, D, Solà, C, Esmatjes, E, Conget, I, Amor, AJ. Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112334. PMID:40543571. IF:7.400(Q1/1D).

01/08/2025 European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines

Karagiannis, T, Advani, A, Davies, MJ, Del Prato, S, Dinneen, SF, Kuss, O, Lorenzoni, V, Mathieu, C, Mauricio, D, Tankova, T, Zaccardi, F, Holt, RIG, Tsapas, A, EASD Guidelines Oversight Comm. European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines. DIABETOLOGIA. 2025; 68(8)DOI:10.1007/s00125-025-06370-1. PMID:40447848. IF:10.200(Q1/1D).

01/08/2025 Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes

Chico, A, Pazos-Couselo, M, Nattero-Chavez, L, Simó-Servat, O, Durán-Martínez, M, Ugarte-Abasolo, E, Aguilera, E, Andía, V, Moreno-Fernández, J, Granados, M, Rebollo, A, Fernandez-Rubio, E, Quirós, C, Alpañés, M, Márquez, R, Beato-Vibora, P, Lado-Baleato, O, Picón-César, M. Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112377. PMID:40695413. IF:7.400(Q1/1D).

01/08/2025 Mitochondrial dysfunction and endoplasmic reticulum stress in atherosclerotic degenerative ascending aortic aneurysm: A transcriptomic analysis

Almendra-Pegueros, R, Barros-Membrilla, A, Perez-Marlasca, E, Tabilo-Ahumada, J, Julve, J, Sanchez-Quesada, JL, Medina-Gómez, G, Martínez-González, JE, Rodríguez, C, Galán, M. Mitochondrial dysfunction and endoplasmic reticulum stress in atherosclerotic degenerative ascending aortic aneurysm: A transcriptomic analysis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).

11/07/2025 Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value

Merino, M, Maravilla-Herrera, P, Artola, S, Escalada, J, Pérez, A, Remón, J, Trillo-Mata, JL, Vallès-Callol, JA, Hidalgo-Vega, A. Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1511108. PMID:40717941. IF:3.400(Q1/2D).

01/07/2025 GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease

Sardà, H, Genua, I, Miñambres, I. GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. MEDICINA CLINICA. 2025; 165(1)DOI:10.1016/j.medcli.2025.106951. PMID:40378625. IF:2.100(Q2/3D).

01/07/2025 Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm

Almendra-Pegueros, R, Barros-Membrilla, AJ, Pérez-Marlasca, E, Julve, J, Martinez-González, J, Rodriguez, C, Galán, M. Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm. Clinica E Investigacion En Arteriosclerosis. 2025; 37(4)DOI:10.1016/j.arteri.2024.09.002. PMID:39424523. IF:(Q/D).

01/07/2025 Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline

Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 193(1)DOI:10.1093/ejendo/lvaf116. PMID:40652450. IF:5.200(Q1/2D).

01/07/2025 The People-First Liver Charter

Lazarus, JV, Wajcman, DI, Pannain, S, Brennan, PN, Manolas, MI, Jepsen, P, Treloar, C, Arora, AK, Matthews, PC, Picchio, CA, White, TM, Grebely, J, Vaz, J, Hagström, H, Rabin, KH, Isaacs, S, Ribeiro, RT, Roden, M, Betel, M, Willemse, J, Díaz, LA, Allen, AM, Alkhouri, N, Schattenberg, JM, Mauricio, D, Rinella, ME, Pose, E, Tsochatzis, EA, Ninburg, M, Cusi, K, Alazawi, W, Duseja, A, Frühbeck, G, Lofton, H, Jaisinghani, P, Kanwal, F, Shiha, G, Zelber-Sagi, S, Holden, L, Villota-Rivas, M. The People-First Liver Charter. NATURE MEDICINE. 2025; 31(7)DOI:10.1038/s41591-025-03759-8. PMID:40473951. IF:50.000(Q1/1D).

06/06/2025 Circulating short-chain fatty acids and Mediterranean food patterns. A potential role for the prediction of type 2 diabetes risk: The Di@bet.es Study

Llauradó, G, Cedo, L, Climent, E, Badia, J, Rojo-Martínez, G, Roux, JFL, Yanes, O, Vinaixa, M, Granado-Casas, M, Mauricio, D, Fernández-Veledo, S, Vendrell, J. Circulating short-chain fatty acids and Mediterranean food patterns. A potential role for the prediction of type 2 diabetes risk: The Di@bet.es Study. BMC Medicine. 2025; 23(1)DOI:10.1186/s12916-025-04186-9. PMID:40481510. IF:8.300(Q1/1D).

27/05/2025 Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes

Rossell, J, Julve, J. Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes. Nutrients. 2025; 17(11)DOI:10.3390/nu17111816. PMID:40507085. IF:5.000(Q1/2D).

21/05/2025 Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis

Mesa, A, Franch-Nadal, J, Navas, E, Mauricio, D. Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02791-9. PMID:40399939. IF:10.600(Q1/1D).

15/05/2025 A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data

Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Génova, A, Reixach, E, Andrés, E, Pizarro, I, Mauricio, D, Perera-Lluna, A. A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data. EXPERT SYSTEMS WITH APPLICATIONS. 2025; 274DOI:10.1016/j.eswa.2025.126876. PMID:. IF:7.500(Q1/1D).

01/05/2025 Managing diabetes across female reproductive stages

Mauricio, D, Gratacòs, M, Franch-Nadal, J. Managing diabetes across female reproductive stages. TRENDS IN ENDOCRINOLOGY AND METABOLISM. 2025; 36(5)DOI:10.1016/j.tem.2025.02.003. PMID:40089417. IF:12.600(Q1/1D).

09/04/2025 Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study

Mesa, A, Puig-Jove, C, Pané, A, Vinagre, I, López-Quesada, E, Meler, E, Alonso-Carril, N, Quirós, C, Amor, AJ, Perea, V. Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02719-3. PMID:40205402. IF:10.600(Q1/1D).

02/04/2025 Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).

01/04/2025 Transitioning between automated insulin delivery systems: A focus on personalisation

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Azriel-Mira, S, Nattero-Chávez, L, Mora, RV, Alonso-Carril, N, Simó-Servat, O, Aguilera-Hurtado, E, Céspedes, LMR, de Adana, MR, Domínguez, M, Márquez-Pardo, R, Díaz-Soto, G, Martínez-Brocca, MA, Fernández, KA, Buesa, MA, Hernández, MC, Quirós, C. Transitioning between automated insulin delivery systems: A focus on personalisation. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112070. PMID:40020785. IF:7.400(Q1/1D).

01/04/2025 Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study

Antonio-Arques, V, Camins, BF, Vlacho, B, Barrot, J, Pérez, JN, Torre, EM, Mauricio, D, Franch-Nadal, J. Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study. Endocrinologia Diabetes y Nutricion. 2025; 72(4)DOI:10.1016/j.endien.2025.501543. PMID:40180835. IF:1.800(Q3/8D).

01/03/2025 Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app

Cuixart, G, Corcoy, R, González, C. Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones-International Journal of Endocrinology and Metabolism. 2025; 24(1)DOI:10.1007/s42000-024-00609-z. PMID:39412732. IF:2.500(Q3/7D).

21/02/2025 Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study

Amigó, N, Castelblanco, E, Julve, J, Martínez-Micaelo, N, Alonso, N, Hernández, M, Ribalta, J, Guardiola, M, Torán-Monserrat, P, Lopez-Lifante, V, Herrero-Alonso, C, Arteaga, I, Ortega, E, Franch-Nadal, J, Mauricio, D. Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02636-5. PMID:39985069. IF:10.600(Q1/1D).

01/02/2025 Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet

Summer, S, Borrell-Pages, M, Bruno, RM, Climie, RE, Dipla, K, Dogan, A, Eruslanova, K, Fraenkel, E, Mattace-Raso, F, Pugh, CJA, Rochfort, KD, Ross, M, Roth, L, Schmidt-Trucksaess, A, Schwarz, D, Shadiow, J, Sohrabi, Y, Sonnenberg, J, Tura-Ceide, O, Tuna, BG, Julve, J, Dogan, S. Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet. GeroScience. 2025; 47(1)DOI:10.1007/s11357-024-01467-8. PMID:39725804. IF:5.400(Q1/1D).

01/02/2025 Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society

Pedro-Botet, J, Arrieta, F, Botana, M, Gimeno-Orna, JA, Martinez-Montoro, JI, de Victoria, EOM, Ribalta, J, Sánchez-Margalet, V, Pérez-Pérez, A. Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society. Endocrinologia Diabetes y Nutricion. 2025; 72(2)DOI:10.1016/j.endien.2025.101523. PMID:39924389. IF:1.800(Q3/8D).

30/01/2025 Expert consensus on vitamin D in osteoporosis

Lei, S, Zhang, XY, Song, LG, Wen, JH, Zhang, Z, Tian, JQ, Yang, R, Xu, SH, Qiu, SH, Macisaac, RJ, Aleksova, J, Mac-Way, F, Dupuis, ME, Benaiges, D, Mauricio, D, Sommer, AP, Barzilay, JI, Gallagher, JC, Pan, LL, Ji, LL, Fang, P, Li, Y, Liu, Q, Zhao, JS, Xue, Y, Shen, YQ, Wang, LM, Han, JF, Liu, GH. Expert consensus on vitamin D in osteoporosis. Annals Of Joint. 2025; 10DOI:10.21037/aoj-24-48. PMID:39981430. IF:(Q/D).

15/02/2024 Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.

Genua I, Cusi K. Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.. Diabetes Spectrum : A Publication Of The American Diabetes Association. 2024; 37(1)DOI:10.2337/dsi23-0012. PMID:38385098. IF:(Q/D).

01/02/2022 Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

Gil, J, Marques-Pamies, M, Valassi, E, Garcia-Martinez, A, Serra, G, Hostalot, C, Fajardo-Montanana, C, Carrato, C, Bernabeu, I, Marazuela, M, Rodriguez-Lloveras, H, Camara, R, Salinas, I, Lamas, C, Biagetti, B, Simo-Servat, A, Webb, SM, Pico, A, Jorda, M, Puig-Domingo, M. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020460. PMID:35203668. IF:4.700(Q1/3D).

01/12/2021 Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly

Losa, M, Resmini, E, Barzaghi, LR, Albano, L, Bailo, M, Webb, SM, Mortini, P. Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly. CLINICAL ENDOCRINOLOGY. 2021; 95(6)DOI:10.1111/cen.14547. PMID:34219264. IF:3.523(Q3/7D).

01/12/2021 Consensus on diagnosis and management of Cushing's disease: a guideline update

Fleseriu, M, Auchus, R, Bancos, I, Ben-Shlomo, A, Bertherat, J, Biermasz, NR, Boguszewski, CL, Bronstein, MD, Buchfelder, M, Carmichael, JD, Casanueva, FF, Castinetti, F, Chanson, P, Findling, J, Gadelha, M, Geer, EB, Giustina, A, Grossman, A, Gurnell, M, Ho, K, Ioachimescu, AG, Kaiser, UB, Karavitaki, N, Katznelson, L, Kelly, DF, Lacroix, A, McCormack, A, Melmed, S, Molitch, M, Mortini, P, Newell-Price, J, Nieman, L, Pereira, AM, Petersenn, S, Pivonello, R, Raff, H, Reincke, M, Salvatori, R, Scaroni, C, Shimon, I, Stratakis, CA, Swearingen, B, Tabarin, A, Takahashi, Y, Theodoropoulou, M, Tsagarakis, S, Valassi, E, Varlamov, EV, Vila, G, Wass, J, Webb, SM, Zatelli, MC, Biller, BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes & Endocrinology. 2021; 9(12)DOI:10.1016/S2213-8587(21)00235-7. PMID:34687601. IF:44.867(Q1/1D).

01/09/2021 ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy

Luger, A, Broersen, LHA, Biermasz, NR, Biller, BMK, Buchfelder, M, Chanson, P, Jorgensen, JOL, Kelestimur, F, Llahana, S, Maiter, D, Mintziori, G, Petraglia, F, Verkauskiene, R, Webb, SM, Dekkers, OM. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 185(3)DOI:10.1530/EJE-21-0462. PMID:34425558. IF:6.558(Q1/2D).

01/09/2021 Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain

Iglesias, P, Nocete, I, Rodriguez, MDM, Venegas-Moreno, E, Ares, J, Biagetti, B, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Villar-Taibo, R, Cordido, F, Paja, M, Glerean, M, Rivera, NG, Fuentes, ED, Blanco, C, Alvarez-Escola, C, Martin, T, Webb, SM, Bernabeu, I, Villabona, C, Soto-Moreno, A, Gaztambide, S, Diez, JJ. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain. NEUROENDOCRINOLOGY. 2021; 111(10)DOI:10.1159/000512161. PMID:33040060. IF:5.135(Q2/4D).